Stay updated on Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.5%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check68 days agoChange DetectedThe web page has undergone significant updates, including the removal of detailed eligibility criteria and treatment protocols for a clinical trial on urothelial cancer, while adding new identifiers and a revision number.SummaryDifference18%
- Check76 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial page.